INTERNATIONAL PATENT: ADAPTIVE BIOTECHNOLOGIES CORPORATION FILES APPLICATION FOR "MULTIPLE SCLEROSIS-ASSOCIATED T CELL RECEPTOR-RELATED METHODS AND COMPOSITIONS"

GENEVA, Aug. 13 -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (1165 Eastlake Avenue EastSeattle, Washington 98102) filed a patent application (PCT/US2025/013882) for "MULTIPLE SCLEROSIS-ASSOCIATED T CELL RECEPTOR-RELATED METHODS AND COMPOSITIONS" on Jan 30, 2025. With publication no. WO/2025/166071, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MATTOX, Daniel (c/o Adaptive Biotechnologies Corporation1165 Eastlake Avenue EastSeattle, Washington 98102), ROBINS, Harlan (c/o Adaptive Biotechnologies Corporation1165 Eastlake Avenu...